INS and obesity due to melanocortin 4 receptor deficiency: As mentioned earlier, patients with pre-existing obesity may have experienced more substantial metabolic improvements, including significant weight loss and improved insulin sensitivity, which are key drivers of glucose normalization and potentially result in higher remission rates [31].